Clovis Oncology, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Clovis Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2021.
  • Clovis Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $4.89M, a 30.2% decline year-over-year.
  • Clovis Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $24M, a 21.2% decline year-over-year.
  • Clovis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25.5M, a 49.9% decline from 2020.
  • Clovis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $50.8M, a 6.46% decline from 2019.
  • Clovis Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $54.3M, a 10.6% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.